Design Therapeutics Inc. (DSGN) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Design Therapeutics Inc.

    NASDAQ: DSGN · Real-Time Price · USD
    6.11
    0.10 (1.58%)
    At close: Oct 03, 2025, 3:59 PM
    6.11
    0.00%
    After-hours: Oct 03, 2025, 04:20 PM EDT

    Design Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -7.04 -2.22 -9.03 -27.68
    PEG Ratio
    		 0.27 -0.51 -0.19 -0.18
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 1.44 0.53 1.75 2.57
    P/FCF Ratio
    		 -8.04 -2.52 -10.94 -31.82
    P/OCF Ratio
    		 -8.1 -2.53 -11.14 -33.48
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.01 0.01 0.01 0.01
    Quick Ratio
    		 29.31 29.58 31.10 72.72
    Current Ratio
    		 29.31 29.58 31.10 72.96
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.2 -0.24 -0.19 -0.09
    Return on Assets
    		 -0.2 -0.23 -0.19 -0.09
    Return on Invested Capital
    		 -0.25 -0.28 -0.2 -0.09
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist